Alnylam Pharmaceuticals
ALNY
#567
Rank
โ‚น3.882 T
Marketcap
โ‚น29,273
Share price
-1.75%
Change (1 day)
38.40%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company